Healthcare

Aptamer Group plc(LSE:APTA) Group produces Optimer® binders, molecules that function similarly to antibodies by binding to specific targets in the body. These binders are applied in therapeutics, diagnostics, and research tools, offering advantages such as high stability, consistent performance, and lower costs compared with …

Renalytix plc (LSE:RENX) (OTCQB:RNLXY), a precision medicine company focused on early-stage risk assessment in chronic kidney disease (CKD), has announced its intention to raise a minimum of £4.0 million in gross proceeds. The capital will be secured through a placing, a subscription of new …

Haleon Plc (LSE:HLN), the world’s largest pure-play consumer health company, has received a vote of confidence fromJefferies, with analystDavid H. Hayesreaffirming aBuyrating on the stock. Hayes set a price target ofAUD 9.00, representing a potential upside of more than20%from the current level ofAUD 7.47.

Oxford Nanopore Technologies plc (LSE:ONT), a developer of nanopore-based molecular sensing technology, has reported a significant increase in revenue for the first half of 2025, supported by broad-based growth across geographies, customer markets, and product ranges.

STIFEL Europe has issued a “Buy” rating on Oxford Biomedica PLC (LSE: OXB).

Genedrive plc (AIM:GDR),a UK-based point-of-care pharmacogenetic testing company, has issued its unaudited trading update for the financial year ended 30 June 2025 (FY25), reporting an anticipated doubling of total income to approximately GBP 1 million compared to GBP 0.5 million in FY24 and GBP …

GSK plc (LON:GSK),a global biopharmaceutical company headquartered in the UK, has announced financial terms related to a recently disclosed mRNA patent settlement between CureVac and BioNTech. As part of this agreement, GSK will receive a total of GBP 370 million upfront, along with ongoing …